Pune, Maharashtra, India
Composition
Metformin Hydrochloride 500mg (Prolonged-Release) + Glimepiride 2mg
Dbglim-M2 is a dual-action oral hypoglycemic medication. Metformin decreases glucose production in the liver, while Glimepiride stimulates insulin secretion from the pancreas, working together to control type 2 diabetes.
Packing
10x15 Tablets
Storage
Cool & dry place
Form
tablet
Quality
FSSAI / GMP
Rx — Prescription Drug. This product should be used only under the supervision and prescription of a registered medical practitioner. Self-medication is not recommended.
* Not everyone experiences these side effects. Consult your doctor if symptoms persist.
Storage Instructions
Store below 25°C. Protect from moisture & light.
Packing
10x15 Tablets
Marketed By
Tawshi Healthcare Pvt. Ltd.
SR. No. 95, Mahadev Nagar, Manjari BK, Hadapsar, Pune – 412307
FSSAI License
11524079000326
Metformin Hydrochloride (SR) Tablets IP 500 mg
Glimepiride 2mg + Voglibose 0.2mg + Metformin Hydrochloride 500mg (SR)
Metformin Hydrochloride 500mg (Prolonged-Release) + Glimepiride 1mg
Gliclazide 30mg + Metformin Hydrochloride 500mg (Extended Release)